| |
| |
|
| Insider
Information: |
Garber Alan M |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
42,177 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,378,488 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,177 |
|
|
| Total
Value |
$3,378,488 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2024-03-21 |
35,703 |
2014-10-14 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2023-05-01 |
6,474 |
2017-06-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
Director |
– • – |
2024-03-21 |
4 |
AS |
$24.01 |
$461,112 |
D/D |
(19,205) |
35,703 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2024-03-21 |
4 |
OE |
$19.57 |
$459,719 |
D/D |
23,491 |
54,908 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
584 |
6,474 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2023-02-21 |
4 |
AS |
$17.49 |
$699,600 |
D/D |
(40,000) |
31,417 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2023-02-21 |
4 |
OE |
$6.30 |
$252,000 |
D/D |
40,000 |
71,417 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2022-03-01 |
4 |
AS |
$21.00 |
$447,321 |
D/D |
(21,301) |
31,417 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2022-03-01 |
4 |
OE |
$3.13 |
$125,200 |
D/D |
40,000 |
52,718 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2021-03-15 |
4 |
OE |
$3.38 |
$135,200 |
D/D |
40,000 |
52,718 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2021-03-15 |
4 |
AS |
$23.60 |
$944,000 |
D/D |
(40,000) |
12,718 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
699 |
5,890 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-05-22 |
4 |
AS |
$24.42 |
$881,831 |
D/D |
(36,111) |
12,718 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-02-14 |
4 |
AS |
$21.02 |
$262,750 |
D/D |
(12,500) |
48,829 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-01-07 |
4 |
AS |
$18.01 |
$1,566,078 |
D/D |
(86,956) |
61,329 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-01-07 |
4 |
OE |
$4.58 |
$468,884 |
D/D |
86,956 |
148,285 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,191 |
5,191 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-04-01 |
4 |
AS |
$23.97 |
$719,550 |
D/D |
(30,000) |
61,329 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-04-01 |
4 |
OE |
$4.57 |
$157,350 |
D/D |
30,000 |
76,329 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-01-08 |
4 |
AS |
$23.00 |
$258,750 |
D/D |
(11,250) |
61,329 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-01-08 |
4 |
OE |
$4.16 |
$46,800 |
D/D |
11,250 |
72,579 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,801 |
4,000 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-04-16 |
4 |
AS |
$20.25 |
$303,750 |
D/D |
(15,000) |
61,329 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-04-16 |
4 |
OE |
$11.66 |
$174,900 |
D/D |
15,000 |
76,329 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-01-09 |
4 |
OE |
$7.97 |
$91,655 |
D/D |
11,500 |
72,829 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-01-09 |
4 |
AS |
$30.00 |
$345,000 |
D/D |
(11,500) |
61,329 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-01-08 |
4 |
AS |
$31.29 |
$109,515 |
D/D |
(3,500) |
61,329 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
